4th Quarter - Report — ALLERGAN USA, INC. for ALLERGAN USA, INC. (2010)

Firm

ALLERGAN USA, INC.

Client

ALLERGAN USA, INC.

Income

—

Expenses

$370,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Prescrition Drug User Fees The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues Drug safety and inspection of drug manufacturing facilities H.R. 759, Food and Drug Administration Globalization Act of 2009 Health Care Reform, including H.R. 3200, Americas Healthy Future Act, S. 1679, the Affordable Health Choices Act, HR 3590, HR 3780, and S. 1728. H.R. 3962, Affordable Healthcare for America S. 3590, Patient Protection and Affordable Care Act H.R. 2847

Lobbyist	Covered position, as disclosed
G THOMAS LONG	—
TED PIPER New	—
ASHLIE VAN METER	—

Contacted: Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3780 (111th), H.R. 2847 (111th), H.R. 3200 (111th), S. 1679 (111th), H.R. 3590 (111th), H.R. 759 (111th), H.R. 3962 (111th), S. 3590 (111th), S. 1728 (111th)

Medicare/Medicaid MMM

Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy

Lobbyist	Covered position, as disclosed
G THOMAS LONG	—
TED PIPER New	—
ASHLIE VAN METER	—

Contacted: Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Copyright/Patent/Trademark CPT

S. 515, H.R. 1260 Patent Reform Act of 2009 H.R. 1427, S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 623 Access to Life Saving Medicine Act S. 369, Preserve Access to Affordable Generics Act of 2009 H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009

Lobbyist	Covered position, as disclosed
G THOMAS LONG	—
TED PIPER New	—
ASHLIE VAN METER	—

Contacted: HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 1260 (111th), H.R. 1548 (111th), S. 623 (111th), S. 369 (111th), H.R. 1427 (111th), S. 515 (111th), S. 726 (111th), H.R. 1706 (111th)

Budget/Appropriations BUD

Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies

Lobbyist	Covered position, as disclosed
G THOMAS LONG	—
TED PIPER New	—
ASHLIE VAN METER	—

Contacted: Medicare Payment Advisory Commission (MedPAC); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

H.R. 306, Kidney Disease Education Benefits Act of 2009 governement partnership opportunities for research and development

Lobbyist	Covered position, as disclosed
G THOMAS LONG	—
TED PIPER New	—
ASHLIE VAN METER	—

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Medicare Payment Advisory Commission (MedPAC)

Bills named: H.R. 306 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.